Full details, including potential risk factors, are given in the Press Release, which can be consulted by clicking on the link below
Nicox’s NCX 470 Dolomites Phase 2 Results Published in Journal of Glaucoma

April 11, 2022

View Press Release Corporate presentation Contact us
Previous